inhibitory glp 1 DPP4 Inhibitors vs GLP-1 Agonists | June 2021 | Clinical Corner Mechanisms of dipeptidyl peptidase‐4 (DPP‐4)

[17] [24] Regular eye monitoring is advised if pre-existing retinopathy is present

It is a fair question, though

Marketing language that promises a face-lift in a week is selling something the underlying biology cannot deliver

Most of the current evidence comes from rodent models, whose pathophysiological processes differ from those of human DKD, and most of the existing studies focus on intervening in early lesions, and their pharmacological effects in reversing structural damage, such as glomerulosclerosis in advanced DKD, remains to be verified

Less commonly reported effects include headaches , hair thinning , and changes in taste perception